His research has focused on the elucidation of the pathological mechanisms of a chronic and fatal fibrotic lung disease. Dr. Nho is currently utilizing novel approaches including drug carrying nanoparticles to selectively target pulmonary cells that are associated with the development of lung disease. His research has been supported by numerous internal and external research grants including National Institute of Health, American Heart Association and American Lung Association.